DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000MG4CYN8

Market Closed - Börse Stuttgart 15:08:03 2024-06-25 EDT
0.116 EUR -17.14% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-61.33%
1 month-74.22%
Date Price Change
24-06-25 0.116 -17.14%
24-06-24 0.14 -5.41%
24-06-21 0.148 +2.07%
24-06-20 0.145 -7.05%
24-06-18 0.156 +20.00%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 03:08 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4CYN
ISINDE000MG4CYN8
Date issued 2024-05-16
Strike 92.5 $
Maturity 2024-12-20 (178 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.113
Spread 0.008
Spread %6.56%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
55.86 USD
Average target price
84.61 USD
Spread / Average Target
+51.46%
Consensus